Therapeutic oligonucleotides
/ edited by Y.S. Cho-chung, Alan M. Gewirtz, and Cy A. Stein
Therapeutic oligonucleotides
Author
/ edited by Y.S. Cho-chung, Alan M. Gewirtz, and Cy A. SteinEdition 1
list
شناسنامه
Title and Author
Therapeutic oligonucleotides / / edited by Y.S. Cho-chung, Alan M. Gewirtz, and Cy A. SteinPublication Details
، 2005مPhysical Description
p. ;cm..Subject
Oligonucleotides ــ Analysisseries
(Annals of the New York Academy of Sciences؛ ;v. 1058)Added Identifiers
Cho-Chung, Yoon S، نویسنده .
Gewirtz, A. M.(Alan M.)، نویسنده .
Stein, Cy A، نویسنده .
New York Academy of Sciences، نویسنده .
Gewirtz, A. M.(Alan M.)، نویسنده .
Stein, Cy A، نویسنده .
New York Academy of Sciences، نویسنده .
Language
انگلیسیRetrieval Number
Congress:
Cataloger
کانورتورIncludes bibliographical references and index.
A phase I pharmacokinetic (PK) and pharmacodynamic (PD) study of OGX-011, a 2'methoxyethyl phosphorothioate antisense to clusterin, in patients with prostate cancer prior to radical prostatectomy / M. Gleave -- Recognition of chromosomal DNA in human cells by peptide nucleic acids and small duplex RNAs / David R. Corey -- Design and development of thermolytic DNA oligonucleotide prodrugs / Andrzej Grajkowski ... [et al.] -- Rationally targeted, conformationally constrained, oxetane-modified oligonucleotides demonstrate efficient gene-silencing activity in a cellular system / J. B. Opalinska and A. M. Gewirtz -- In vivo potentialities of EWS-FLI-1 targeted antisense oligonucleotides-nanospheres complexes / Andrei Maksimenko ... [et al.] -- Endo-porter: a novel reagent for safe, effective delivery of substances into cells / James E. Summerton -- Tumor reversion: protein kinase a isozyme switching / Yoon S. Cho-chung and Maria V. Nesterova -- Therapeutic potential of oligonucleotides expressing immunosuppressive TTAGGG motifs / Dennis M. Klinman ... [et al.] -- Breaking tolerance to tumors with dendritic cell-based immunotherapy / Ines Mende and Edgar G. Engleman --A phase I pharmacokinetic (PK) and pharmacodynamic (PD) study of OGX-011, a 2'methoxyethyl phosphorothioate antisense to clusterin, in patients with prostate cancer prior to radical prostatectomy / M. Gleave -- Recognition of chromosomal DNA in human cells by peptide nucleic acids and small duplex RNAs / David R. Core.
A phase I pharmacokinetic (PK) and pharmacodynamic (PD) study of OGX-011, a 2'methoxyethyl phosphorothioate antisense to clusterin, in patients with prostate cancer prior to radical prostatectomy / M. Gleave -- Recognition of chromosomal DNA in human cells by peptide nucleic acids and small duplex RNAs / David R. Corey -- Design and development of thermolytic DNA oligonucleotide prodrugs / Andrzej Grajkowski ... [et al.] -- Rationally targeted, conformationally constrained, oxetane-modified oligonucleotides demonstrate efficient gene-silencing activity in a cellular system / J. B. Opalinska and A. M. Gewirtz -- In vivo potentialities of EWS-FLI-1 targeted antisense oligonucleotides-nanospheres complexes / Andrei Maksimenko ... [et al.] -- Endo-porter: a novel reagent for safe, effective delivery of substances into cells / James E. Summerton -- Tumor reversion: protein kinase a isozyme switching / Yoon S. Cho-chung and Maria V. Nesterova -- Therapeutic potential of oligonucleotides expressing immunosuppressive TTAGGG motifs / Dennis M. Klinman ... [et al.] -- Breaking tolerance to tumors with dendritic cell-based immunotherapy / Ines Mende and Edgar G. Engleman --A phase I pharmacokinetic (PK) and pharmacodynamic (PD) study of OGX-011, a 2'methoxyethyl phosphorothioate antisense to clusterin, in patients with prostate cancer prior to radical prostatectomy / M. Gleave -- Recognition of chromosomal DNA in human cells by peptide nucleic acids and small duplex RNAs / David R. Core.
